| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.977 | 0.004 | 0.994 | Cyclophilin D inhibitor | 0.994 0.003 DBMET01365 0.943 0.004 DBMET00295 0.955 0.004 DBMET00296 0.988 0.003 DBMET00942 0.953 0.004 DBMET00470 0.974 0.004 DBMET00936 0.975 0.004 DBMET00938 0.966 0.004 DBMET01111 0.975 0.004 DBMET00981 0.976 0.004 DBMET01112 0.98 0.004 DBMET00968 0.965 0.004 DBMET00969 0.964 0.004 DBMET00937 0.976 0.004 DBMET01113 | DBMET01365 | |
| 0.888 | 0.002 | 0.947 | Insulin sensitizer | 0.947 0.001 DBMET01365 0.45 0.004 DBMET00295 0.761 0.002 DBMET00296 0.733 0.002 DBMET00942 0.605 0.003 DBMET00470 0.512 0.004 DBMET00936 0.537 0.003 DBMET00938 0.387 0.007 DBMET01111 0.921 0.001 DBMET00981 0.652 0.003 DBMET01112 0.72 0.002 DBMET00968 0.519 0.004 DBMET00969 0.35 0.009 DBMET00937 0.371 0.008 DBMET01113 | DBMET01365 | |
| 0.848 | 0.004 | 0.921 | Hypoglycemic | 0.921 0.003 DBMET01365 0.778 0.004 DBMET00295 0.811 0.004 DBMET00296 0.89 0.003 DBMET00942 0.778 0.004 DBMET00470 0.82 0.004 DBMET00936 0.828 0.004 DBMET00938 0.87 0.004 DBMET01111 0.88 0.004 DBMET00981 0.733 0.005 DBMET01112 0.883 0.004 DBMET00968 0.709 0.005 DBMET00969 0.716 0.005 DBMET00937 0.722 0.005 DBMET01113 | DBMET01365 | |
| 0.814 | 0 | 0.911 | Thiazolidinedione | 0.911 0 DBMET01365 0.28 0.001 DBMET00295 0.324 0.001 DBMET00296 0.906 0 DBMET00942 0.305 0.001 DBMET00470 0.523 0 DBMET00936 0.557 0 DBMET00938 0.174 0.001 DBMET01111 0.32 0.001 DBMET00981 0.439 0 DBMET01112 0.307 0.001 DBMET00968 0.41 0 DBMET00969 0.389 0 DBMET00937 0.401 0 DBMET01113 | DBMET01365 | |
| 0.64 | 0.003 | 0.859 | Peroxisome proliferator-activated receptor gamma agonist | 0.859 0.002 DBMET01365 0.397 0.004 DBMET00295 0.508 0.003 DBMET00296 0.736 0.003 DBMET00942 0.461 0.004 DBMET00470 0.565 0.003 DBMET00936 0.575 0.003 DBMET00938 0.27 0.005 DBMET01111 0.489 0.004 DBMET00981 0.474 0.004 DBMET01112 0.415 0.004 DBMET00968 0.431 0.004 DBMET00969 0.403 0.004 DBMET00937 0.412 0.004 DBMET01113 | DBMET01365 | |
| 0.637 | 0.005 | 0.818 | Hypolipemic | 0.818 0.004 DBMET01365 0.532 0.01 DBMET00295 0.597 0.007 DBMET00296 0.729 0.004 DBMET00942 0.521 0.011 DBMET00470 0.609 0.006 DBMET00936 0.658 0.005 DBMET00938 0.521 0.011 DBMET01111 0.614 0.006 DBMET00981 0.549 0.009 DBMET01112 0.581 0.007 DBMET00968 0.521 0.011 DBMET00969 0.533 0.01 DBMET00937 0.542 0.009 DBMET01113 | DBMET01365 | |
| 0.52 | 0.003 | 0.52 | Sodium/bile acid cotransporter inhibitor | 0.513 0.003 DBMET01365 0.443 0.008 DBMET00295 0.487 0.004 DBMET00296 0.506 0.004 DBMET00942 0.475 0.005 DBMET00470 0.481 0.005 DBMET00936 0.482 0.005 DBMET00938 0.4 0.017 DBMET01111 0.476 0.005 DBMET00981 0.499 0.004 DBMET01112 0.467 0.005 DBMET00968 0.49 0.004 DBMET00969 0.465 0.006 DBMET00937 0.466 0.006 DBMET01113 | ||
| 0.478 | 0.042 | 0.763 | Antiobesity | 0.667 0.014 DBMET01365 0.287 0.126 DBMET00296 0.52 0.033 DBMET00942 0.257 0.15 DBMET00936 0.412 0.061 DBMET00938 0.229 0.178 DBMET01111 0.528 0.032 DBMET00981 0.763 0.007 DBMET01112 0.404 0.064 DBMET00968 0.402 0.065 DBMET00969 0.367 0.079 DBMET00937 0.747 0.008 DBMET01113 | DBMET01112 | |
| 0.354 | 0.025 | 0.488 | Cyclic AMP phosphodiesterase inhibitor | 0.353 0.025 DBMET01365 0.228 0.076 DBMET00295 0.256 0.061 DBMET00296 0.259 0.059 DBMET00942 0.236 0.071 DBMET00470 0.249 0.064 DBMET00936 0.2 0.093 DBMET00938 0.401 0.016 DBMET01111 0.488 0.007 DBMET00981 0.47 0.009 DBMET00968 | DBMET00981 | |
| 0.328 | 0.004 | 0.652 | Aldose reductase inhibitor | 0.652 0.002 DBMET01365 0.232 0.005 DBMET00295 0.219 0.006 DBMET00296 0.489 0.003 DBMET00942 0.22 0.006 DBMET00470 0.359 0.004 DBMET00936 0.365 0.004 DBMET00938 0.223 0.006 DBMET01111 0.298 0.004 DBMET00981 0.31 0.004 DBMET01112 0.299 0.004 DBMET00968 0.311 0.004 DBMET00969 0.335 0.004 DBMET00937 0.339 0.004 DBMET01113 | DBMET01365 | |
| 0.325 | 0.005 | 0.466 | ABCA1 expression enhancer | 0.466 0.004 DBMET01365 0.137 0.021 DBMET00295 0.191 0.01 DBMET00296 0.355 0.004 DBMET00942 0.163 0.014 DBMET00470 0.218 0.008 DBMET00936 0.233 0.007 DBMET00938 0.173 0.013 DBMET00981 0.228 0.007 DBMET01112 0.153 0.017 DBMET00968 0.202 0.009 DBMET00969 0.17 0.013 DBMET00937 0.182 0.011 DBMET01113 | DBMET01365 | |
| 0.351 | 0.039 | 0.422 | Cardiotonic | 0.278 0.066 DBMET01365 0.214 0.107 DBMET00296 0.422 0.025 DBMET00942 0.185 0.135 DBMET00936 0.271 0.069 DBMET00938 0.262 0.075 DBMET00981 0.182 0.137 DBMET01112 0.176 0.144 DBMET00968 | DBMET00942 | |
| 0.283 | 0.004 | 0.428 | Adrenaline agonist | 0.361 0.003 DBMET01365 0.138 0.018 DBMET00295 0.114 0.028 DBMET00296 0.428 0.003 DBMET00942 0.114 0.029 DBMET00470 0.35 0.003 DBMET00936 0.295 0.004 DBMET00938 0.119 0.026 DBMET01112 0.119 0.026 DBMET00969 0.157 0.013 DBMET00937 0.119 0.026 DBMET01113 | DBMET00942 | |
| 0.287 | 0.017 | 0.294 | Interleukin 6 antagonist | 0.294 0.015 DBMET01365 0.186 0.05 DBMET00295 0.177 0.058 DBMET00296 0.289 0.016 DBMET00942 0.172 0.062 DBMET00470 0.243 0.024 DBMET00936 0.243 0.024 DBMET00938 0.208 0.036 DBMET01111 0.29 0.016 DBMET00981 0.142 0.101 DBMET01112 0.286 0.017 DBMET00968 0.139 0.108 DBMET00969 0.129 0.126 DBMET00937 0.129 0.127 DBMET01113 | DBMET01365 | |
| 0.255 | 0.025 | 0.371 | NOS3 expression enhancer | 0.371 0.01 DBMET01365 0.184 0.048 DBMET00295 0.155 0.068 DBMET00296 0.275 0.022 DBMET00942 0.132 0.095 DBMET00470 0.296 0.018 DBMET00936 0.342 0.012 DBMET00938 0.286 0.02 DBMET01111 0.364 0.01 DBMET00981 0.204 0.039 DBMET01112 0.345 0.012 DBMET00968 0.177 0.052 DBMET00969 0.21 0.037 DBMET00937 0.262 0.024 DBMET01113 | DBMET01365 | |
| 0.227 | 0.003 | 0.653 | Free fatty acid receptor 1 agonist | 0.653 0.002 DBMET01365 0.129 0.004 DBMET00295 0.129 0.004 DBMET00296 0.364 0.003 DBMET00942 0.112 0.004 DBMET00470 0.199 0.003 DBMET00936 0.217 0.003 DBMET00938 0.033 0.005 DBMET01111 0.082 0.004 DBMET00981 0.105 0.004 DBMET01112 0.062 0.004 DBMET00968 0.094 0.004 DBMET00969 0.104 0.004 DBMET00937 0.111 0.004 DBMET01113 | DBMET01365 | |
| 0.219 | 0.02 | 0.234 | Alpha 2b adrenoreceptor antagonist | 0.234 0.017 DBMET00942 | DBMET00942 | |
| 0.254 | 0.067 | 0.367 | Vasodilator | 0.313 0.044 DBMET01365 0.156 0.148 DBMET00296 0.367 0.029 DBMET00942 0.233 0.08 DBMET00470 0.321 0.041 DBMET00936 0.189 0.114 DBMET00938 0.293 0.051 DBMET01111 0.358 0.031 DBMET00981 0.339 0.036 DBMET00968 0.157 0.146 DBMET00937 | DBMET00942 | |
| 0.205 | 0.033 | 0.505 | Insulin secretagoues | 0.505 0.005 DBMET01365 0.235 0.023 DBMET00295 0.328 0.01 DBMET00942 0.313 0.011 DBMET00936 0.341 0.009 DBMET00938 0.31 0.011 DBMET01111 0.317 0.01 DBMET00981 0.309 0.011 DBMET00968 0.181 0.047 DBMET00937 0.199 0.036 DBMET01113 | DBMET01365 | |
| 0.203 | 0.041 | 0.317 | Lipid peroxidase inhibitor | 0.317 0.017 DBMET01365 0.116 0.099 DBMET00296 0.271 0.023 DBMET00942 0.231 0.031 DBMET00936 0.238 0.029 DBMET00938 0.212 0.037 DBMET01111 0.312 0.017 DBMET00981 0.204 0.04 DBMET01112 0.294 0.02 DBMET00968 0.186 0.048 DBMET00969 0.204 0.04 DBMET00937 0.209 0.038 DBMET01113 | DBMET01365 | |
| 0.166 | 0.005 | 0.577 | Peroxisome proliferator-activated receptor gamma antagonist | 0.577 0.002 DBMET01365 0.067 0.06 DBMET00295 0.079 0.036 DBMET00296 0.183 0.004 DBMET00942 0.078 0.037 DBMET00470 0.103 0.014 DBMET00936 0.097 0.017 DBMET00938 0.074 0.043 DBMET00981 0.073 0.046 DBMET01112 0.074 0.045 DBMET00968 0.072 0.047 DBMET00969 | DBMET01365 | |
| 0.151 | 0.004 | 0.247 | Estrogen-related receptor alpha antagonist | 0.247 0.003 DBMET01365 0.046 0.015 DBMET00295 0.045 0.015 DBMET00296 0.246 0.003 DBMET00942 0.045 0.015 DBMET00470 0.161 0.004 DBMET00936 0.161 0.004 DBMET00938 0.079 0.008 DBMET00981 0.103 0.006 DBMET01112 0.079 0.008 DBMET00968 0.103 0.006 DBMET00969 0.112 0.005 DBMET00937 0.112 0.005 DBMET01113 | DBMET01365 | |
| 0.161 | 0.022 | 0.647 | AMP-activated protein kinase stimulant | 0.225 0.008 DBMET01365 0.108 0.06 DBMET00296 0.159 0.023 DBMET00942 0.13 0.041 DBMET00936 0.157 0.024 DBMET00938 0.172 0.017 DBMET01111 0.647 0.002 DBMET00981 0.39 0.004 DBMET00968 | DBMET00981 | |
| 0.167 | 0.053 | 0.325 | MAO inhibitor | 0.154 0.058 DBMET01365 0.216 0.036 DBMET00295 0.222 0.035 DBMET00296 0.325 0.017 DBMET00942 0.296 0.021 DBMET00470 0.174 0.05 DBMET00936 0.112 0.08 DBMET00938 | DBMET00942 | |
| 0.135 | 0.023 | 0.264 | Telomerase inhibitor | 0.176 0.017 DBMET01365 0.264 0.008 DBMET00942 0.149 0.02 DBMET00936 0.138 0.022 DBMET00938 0.066 0.057 DBMET00968 | DBMET00942 | |
| 0.13 | 0.023 | 0.17 | Toll-Like receptor 3 antagonist | 0.115 0.033 DBMET00295 0.17 0.01 DBMET00942 0.106 0.043 DBMET00470 0.108 0.04 DBMET00936 0.086 0.079 DBMET00969 0.085 0.081 DBMET00937 | DBMET00942 | |
| 0.117 | 0.011 | 0.186 | Maillard reaction inhibitor | 0.186 0.004 DBMET01365 0.048 0.046 DBMET00296 0.156 0.005 DBMET00942 0.13 0.008 DBMET00936 0.133 0.008 DBMET00938 0.107 0.014 DBMET00981 0.074 0.027 DBMET01112 0.104 0.015 DBMET00968 0.068 0.03 DBMET00969 0.071 0.028 DBMET00937 0.077 0.026 DBMET01113 | DBMET01365 | |
| 0.113 | 0.01 | 0.548 | Peroxisome proliferator-activated receptor alpha agonist | 0.548 0.002 DBMET01365 0.045 0.036 DBMET00296 0.146 0.006 DBMET00942 0.069 0.023 DBMET00936 0.075 0.02 DBMET00938 0.061 0.026 DBMET00981 0.042 0.04 DBMET00968 | DBMET01365 | |
| 0.098 | 0.005 | 0.311 | Peroxisome proliferator-activated receptor delta antagonist | 0.311 0.003 DBMET01365 0.033 0.024 DBMET00296 0.11 0.005 DBMET00942 0.031 0.028 DBMET00470 0.046 0.011 DBMET00936 0.045 0.011 DBMET00938 0.039 0.015 DBMET00981 0.039 0.015 DBMET01112 0.038 0.017 DBMET00968 0.038 0.017 DBMET00969 0.031 0.028 DBMET00937 0.03 0.029 DBMET01113 | DBMET01365 | |
| 0.148 | 0.06 | 0.382 | Bone formation stimulant | 0.332 0.014 DBMET01365 0.15 0.059 DBMET00295 0.114 0.091 DBMET00296 0.245 0.026 DBMET00942 0.134 0.073 DBMET00470 0.382 0.011 DBMET00936 0.279 0.02 DBMET00938 0.178 0.042 DBMET01111 0.144 0.064 DBMET00981 0.108 0.097 DBMET01112 0.141 0.066 DBMET00968 0.104 0.102 DBMET00969 0.23 0.029 DBMET00937 0.163 0.05 DBMET01113 | DBMET00936 | |
| 0.092 | 0.004 | 0.228 | Beta adrenoreceptor agonist | 0.226 0.002 DBMET01365 0.056 0.01 DBMET00295 0.049 0.02 DBMET00296 0.228 0.002 DBMET00942 0.048 0.021 DBMET00470 0.135 0.003 DBMET00936 0.137 0.003 DBMET00938 0.044 0.038 DBMET00981 0.052 0.014 DBMET01112 0.043 0.04 DBMET00968 0.052 0.015 DBMET00969 0.057 0.01 DBMET00937 0.057 0.01 DBMET01113 | DBMET00942 | |
| 0.107 | 0.024 | 0.149 | Lipase inhibitor | 0.149 0.01 DBMET01365 0.075 0.048 DBMET00295 0.149 0.01 DBMET00942 0.126 0.015 DBMET00936 0.121 0.017 DBMET00938 0.092 0.032 DBMET00981 0.088 0.035 DBMET00968 0.075 0.048 DBMET00937 0.068 0.056 DBMET01113 | DBMET00942 | |
| 0.129 | 0.046 | 0.225 | MAO B inhibitor | 0.112 0.054 DBMET01365 0.14 0.041 DBMET00295 0.178 0.029 DBMET00296 0.225 0.02 DBMET00942 0.217 0.021 DBMET00470 0.111 0.055 DBMET00936 0.083 0.072 DBMET00938 | DBMET00942 | |
| 0.077 | 0.011 | 0.109 | Beta 2 adrenoreceptor agonist | 0.102 0.004 DBMET01365 0.061 0.044 DBMET00296 0.109 0.004 DBMET00942 0.081 0.009 DBMET00936 0.088 0.005 DBMET00938 0.065 0.033 DBMET01112 0.059 0.056 DBMET00969 0.059 0.054 DBMET00937 0.064 0.035 DBMET01113 | DBMET00942 | |
| 0.091 | 0.028 | 0.117 | Phosphodiesterase III inhibitor | 0.117 0.016 DBMET01365 0.102 0.022 DBMET00942 0.068 0.045 DBMET00470 0.077 0.038 DBMET00936 0.061 0.051 DBMET00938 | DBMET01365 | |
| 0.106 | 0.051 | 0.13 | Nitric-oxide synthase inhibitor | 0.13 0.032 DBMET00942 | DBMET00942 | |
| 0.203 | 0.156 | 0.203 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.062 | 0.019 | 0.1 | Phosphodiesterase 3B inhibitor | 0.1 0.011 DBMET01365 0.052 0.024 DBMET00295 0.054 0.022 DBMET00296 0.056 0.021 DBMET00942 0.066 0.018 DBMET00470 0.053 0.023 DBMET00936 0.045 0.029 DBMET00938 | DBMET01365 | |
| 0.06 | 0.024 | 0.119 | Beta 2 adrenoreceptor antagonist | 0.089 0.009 DBMET01365 0.057 0.027 DBMET00295 0.046 0.042 DBMET00296 0.119 0.006 DBMET00942 0.047 0.041 DBMET00470 0.07 0.017 DBMET00936 0.073 0.015 DBMET00938 | DBMET00942 | |
| 0.186 | 0.156 | 0.433 | Lipoxygenase inhibitor | 0.433 0.03 DBMET01365 0.197 0.144 DBMET00295 0.249 0.101 DBMET00942 0.176 0.169 DBMET00470 0.19 0.15 DBMET00936 0.201 0.139 DBMET00938 | DBMET01365 | |
| 0.085 | 0.055 | 0.101 | Inducible nitric-oxide synthase inhibitor | 0.084 0.055 DBMET01365 0.101 0.036 DBMET00942 | DBMET00942 | |
| 0.216 | 0.19 | 0.436 | Calcium channel activator | 0.357 0.046 DBMET01365 0.436 0.014 DBMET00942 0.237 0.163 DBMET00936 0.216 0.19 DBMET00938 | DBMET00942 | |
| 0.032 | 0.007 | 0.182 | Beta 1 adrenoreceptor agonist | 0.182 0.002 DBMET01365 0.024 0.014 DBMET00295 0.153 0.002 DBMET00942 0.056 0.004 DBMET00936 0.077 0.003 DBMET00938 0.022 0.017 DBMET00937 0.025 0.012 DBMET01113 | DBMET01365 | |
| 0.028 | 0.004 | 0.23 | Beta 3 adrenoreceptor agonist | 0.23 0.002 DBMET01365 0.014 0.006 DBMET00295 0.144 0.003 DBMET00942 0.095 0.003 DBMET00936 0.09 0.003 DBMET00938 0.011 0.009 DBMET00937 0.01 0.009 DBMET01113 | DBMET01365 | |
| 0.091 | 0.074 | 0.125 | Bronchodilator | 0.125 0.042 DBMET01365 0.12 0.045 DBMET00942 0.091 0.074 DBMET00936 0.091 0.074 DBMET00938 | DBMET01365 | |
| 0.124 | 0.109 | 0.425 | Protein-tyrosine phosphatase inhibitor | 0.425 0.007 DBMET01365 0.153 0.075 DBMET00942 0.139 0.091 DBMET00936 0.135 0.095 DBMET00938 0.144 0.085 DBMET00981 0.252 0.03 DBMET01112 0.143 0.086 DBMET00968 0.251 0.03 DBMET00969 0.264 0.027 DBMET00937 0.26 0.028 DBMET01113 | DBMET01365 | |
| 0.025 | 0.013 | 0.32 | Peroxisome proliferator-activated receptor alpha antagonist | 0.32 0.002 DBMET01365 0.031 0.011 DBMET00942 | DBMET01365 | |
| 0.078 | 0.073 | 0.123 | Estrogen-related receptor beta agonist | 0.113 0.013 DBMET01365 0.123 0.009 DBMET00942 0.084 0.056 DBMET00936 0.084 0.056 DBMET00938 | DBMET00942 | |
| 0.049 | 0.047 | 0.126 | Beta 1 adrenoreceptor antagonist | 0.091 0.013 DBMET01365 0.067 0.029 DBMET00295 0.126 0.006 DBMET00942 0.075 0.021 DBMET00936 0.08 0.018 DBMET00938 | DBMET00942 | |
| 0.09 | 0.089 | 0.382 | Protein-tyrosine phosphatase 1B inhibitor | 0.382 0.006 DBMET01365 0.13 0.056 DBMET00942 0.1 0.078 DBMET00936 0.101 0.077 DBMET00938 0.127 0.058 DBMET00981 0.161 0.041 DBMET01112 0.122 0.062 DBMET00968 0.152 0.044 DBMET00969 0.162 0.041 DBMET00937 0.163 0.041 DBMET01113 | DBMET01365 | |
| 0.051 | 0.057 | 0.088 | Phosphodiesterase 1B inhibitor | 0.088 0.019 DBMET01365 0.06 0.041 DBMET00942 0.07 0.031 DBMET00936 | DBMET01365 | |
| 0.022 | 0.029 | 0.543 | Thyroid hormone agonist | 0.543 0.001 DBMET01365 0.067 0.004 DBMET00942 0.06 0.004 DBMET00936 0.065 0.004 DBMET00938 0.041 0.006 DBMET01112 0.037 0.007 DBMET00969 0.072 0.003 DBMET00937 0.079 0.003 DBMET01113 | DBMET01365 | |
| 0.026 | 0.034 | 0.18 | Peroxisome proliferator-activated receptor delta agonist | 0.18 0.003 DBMET01365 0.033 0.024 DBMET00942 | DBMET01365 | |
| 0.014 | 0.027 | 0.029 | Aggrecanase 2 inhibitor | 0.029 0.01 DBMET01365 0.023 0.014 DBMET00942 | DBMET01365 | |
| 0.075 | 0.088 | 0.093 | Pim-1 kinase inhibitor | 0.093 0.064 DBMET00938 | DBMET00938 | |
| 0.045 | 0.061 | 0.09 | Thromboxane synthase inhibitor | 0.09 0.008 DBMET01365 0.053 0.042 DBMET00936 | DBMET01365 | |
| 0.068 | 0.084 | 0.148 | Antiadrenergic | 0.148 0.036 DBMET00942 | DBMET00942 | |
| 0.01 | 0.028 | 0.039 | Ileal bile acid transport inhibitor | 0.032 0.005 DBMET01365 0.039 0.004 DBMET00981 0.032 0.005 DBMET00968 | DBMET00981 | |
| 0.051 | 0.072 | 0.122 | Beta adrenoreceptor antagonist | 0.098 0.017 DBMET01365 0.122 0.01 DBMET00942 0.069 0.04 DBMET00936 0.072 0.035 DBMET00938 | DBMET00942 | |
| 0.004 | 0.025 | 0.466 | Thyroid hormone beta agonist | 0.466 0.001 DBMET01365 0.024 0.003 DBMET00942 0.018 0.004 DBMET00936 0.022 0.004 DBMET00938 | DBMET01365 | |
| 0.042 | 0.064 | 0.112 | 5 Hydroxytryptamine 1B agonist | 0.112 0.005 DBMET00942 | DBMET00942 | |
| 0.064 | 0.086 | 0.144 | Adrenaline antagonist | 0.144 0.036 DBMET00942 | DBMET00942 | |
| 0.053 | 0.092 | 0.083 | Alpha 2a adrenoreceptor antagonist | 0.083 0.046 DBMET00942 | DBMET00942 | |
| 0.139 | 0.179 | 0.441 | Antioxidant | 0.288 0.066 DBMET01365 0.223 0.1 DBMET00942 0.188 0.124 DBMET00936 0.192 0.12 DBMET00938 0.399 0.035 DBMET01111 0.441 0.028 DBMET00981 0.238 0.09 DBMET01112 0.439 0.028 DBMET00968 0.236 0.092 DBMET00969 0.241 0.089 DBMET00937 0.245 0.087 DBMET01113 | DBMET00981 | |
| 0.143 | 0.183 | 0.154 | MAP kinase kinase 5 inhibitor | 0.154 0.138 DBMET00942 | DBMET00942 | |
| 0.006 | 0.054 | 0.048 | Prostacyclin agonist | 0.048 0.004 DBMET01365 | DBMET01365 | |
| 0.014 | 0.064 | 0.054 | Leukotriene A4 hydrolase inhibitor | 0.054 0.018 DBMET01365 0.042 0.024 DBMET00942 | DBMET01365 | |
| 0.114 | 0.164 | 0.323 | Hepatoprotectant | 0.22 0.054 DBMET01365 0.182 0.078 DBMET00942 0.302 0.029 DBMET01111 0.32 0.024 DBMET00981 0.162 0.097 DBMET01112 0.323 0.024 DBMET00968 0.166 0.094 DBMET00969 0.158 0.102 DBMET00937 0.16 0.099 DBMET01113 | DBMET00968 | |
| 0.064 | 0.121 | 0.1 | Phosphodiesterase I inhibitor | 0.1 0.044 DBMET01365 | DBMET01365 | |
| 0.083 | 0.143 | 0.233 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.134 0.089 DBMET00936 0.233 0.041 DBMET00938 | DBMET00938 | |
| 0.032 | 0.098 | 0.07 | Myc inhibitor | 0.07 0.019 DBMET00942 | DBMET00942 | |
| 0.018 | 0.088 | 0.046 | Estrogen-related receptor gamma antagonist | 0.027 0.024 DBMET01365 0.046 0.004 DBMET00942 | DBMET00942 | |
| 0.09 | 0.166 | 0.147 | Neurotrophic factor | 0.123 0.091 DBMET01365 0.147 0.062 DBMET00942 0.112 0.109 DBMET00936 | DBMET00942 | |
| 0.139 | 0.223 | 0.413 | Thyroid hormone antagonist | 0.413 0.052 DBMET01365 | DBMET01365 | |
| 0.016 | 0.107 | 0.062 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.062 0.005 DBMET01365 | DBMET01365 | |
| 0.128 | 0.224 | 0.443 | Prostaglandin dehydrogenase inhibitor | 0.443 0.055 DBMET01365 0.338 0.087 DBMET00942 0.201 0.156 DBMET00936 | DBMET01365 | |
| 0.145 | 0.243 | 0.247 | 5 Hydroxytryptamine 3E antagonist | 0.247 0.017 DBMET00942 | DBMET00942 | |
| 0.02 | 0.12 | 0.041 | Liver X receptor alpha agonist | 0.041 0.028 DBMET01365 | DBMET01365 | |
| 0.023 | 0.126 | 0.037 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.016 DBMET01365 | DBMET01365 | |
| 0.09 | 0.195 | 0.222 | Growth hormone agonist | 0.222 0.051 DBMET01365 0.134 0.102 DBMET00942 | DBMET01365 | |
| 0.037 | 0.153 | 0.091 | Potassium channel (ATP-sensitive) blocker | 0.091 0.02 DBMET00295 | DBMET00295 | |
| 0.009 | 0.13 | 0.07 | Retinoid X receptor agonist | 0.07 0.01 DBMET01365 | DBMET01365 | |
| 0.183 | 0.306 | 0.51 | Calcium channel L-type activator | 0.324 0.137 DBMET01365 0.51 0.024 DBMET00942 | DBMET00942 | |
| 0.066 | 0.199 | 0.111 | Estrogen antagonist | 0.103 0.09 DBMET01365 0.105 0.086 DBMET00296 0.101 0.097 DBMET00942 0.111 0.073 DBMET00938 | DBMET00938 | |
| 0.133 | 0.274 | 0.174 | Nitric-oxide synthase stimulant | 0.168 0.159 DBMET00936 0.174 0.143 DBMET00938 | DBMET00938 | |
| 0.126 | 0.286 | 0.24 | Vasodilator, peripheral | 0.24 0.135 DBMET01365 | DBMET01365 | |
| 0.006 | 0.168 | 0.042 | Uridine phosphorylase inhibitor | 0.042 0.011 DBMET01365 | DBMET01365 | |
| 0.041 | 0.212 | 0.099 | Gastric antisecretory | 0.099 0.068 DBMET00937 | DBMET00937 | |
| 0.044 | 0.218 | 0.073 | Estrogen receptor alpha antagonist | 0.073 0.061 DBMET01365 | DBMET01365 | |
| 0.036 | 0.215 | 0.058 | Bcl-xL inhibitor | 0.058 0.048 DBMET01365 | DBMET01365 | |
| 0.005 | 0.186 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 DBMET01365 | DBMET01365 | |
| 0.046 | 0.229 | 0.098 | Estrogen receptor beta antagonist | 0.089 0.084 DBMET00296 0.098 0.068 DBMET00938 | DBMET00938 | |
| 0.109 | 0.298 | 0.228 | Gastrin inhibitor | 0.228 0.107 DBMET01365 0.207 0.139 DBMET00942 | DBMET01365 | |
| 0.118 | 0.312 | 0.293 | Vasodilator, coronary | 0.23 0.154 DBMET00942 0.237 0.147 DBMET01111 0.293 0.093 DBMET00981 0.255 0.13 DBMET00968 | DBMET00981 | |
| 0.004 | 0.204 | 0.036 | Prostaglandin EP2 agonist | 0.036 0.01 DBMET01365 | DBMET01365 | |
| 0.025 | 0.225 | 0.087 | MAO A inhibitor | 0.087 0.073 DBMET00942 | DBMET00942 | |
| 0.073 | 0.285 | 0.354 | Hemostatic | 0.126 0.102 DBMET01365 0.144 0.076 DBMET01111 0.258 0.021 DBMET00981 0.208 0.03 DBMET01112 0.169 0.049 DBMET00968 0.147 0.072 DBMET00969 0.275 0.019 DBMET00937 0.354 0.011 DBMET01113 | DBMET01113 | |
| 0.003 | 0.222 | 0.036 | Prostaglandin E2 agonist | 0.036 0.008 DBMET01365 | DBMET01365 | |
| 0.068 | 0.29 | 0.281 | Platelet adhesion inhibitor | 0.164 0.093 DBMET01111 0.281 0.04 DBMET00981 0.196 0.073 DBMET01112 0.234 0.055 DBMET00968 0.149 0.107 DBMET00969 | DBMET00981 | |
| 0.072 | 0.296 | 0.19 | Adenylate cyclase stimulant | 0.171 0.034 DBMET01365 0.19 0.018 DBMET00942 | DBMET00942 | |
| 0.01 | 0.264 | 0.056 | Cyclophilin A inhibitor | 0.056 0.005 DBMET00936 0.034 0.017 DBMET01111 0.04 0.012 DBMET00937 | DBMET00936 | |
| 0.11 | 0.364 | 0.317 | Peptidyltransferase inhibitor | 0.17 0.146 DBMET00942 0.306 0.022 DBMET01111 0.313 0.02 DBMET00981 0.317 0.019 DBMET00968 | DBMET00968 | |
| 0.015 | 0.271 | 0.068 | Collagenase 3 inhibitor | 0.068 0.034 DBMET01365 0.064 0.037 DBMET00942 | DBMET01365 | |
| 0.043 | 0.3 | 0.17 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.17 0.101 DBMET00938 | DBMET00938 | |
| 0.005 | 0.267 | 0.026 | Thyroid hormone alpha agonist | 0.026 0.004 DBMET01365 | DBMET01365 | |
| 0.114 | 0.377 | 0.325 | Apoptosis antagonist | 0.325 0.07 DBMET01365 0.211 0.165 DBMET00942 0.3 0.085 DBMET01111 0.313 0.077 DBMET00981 0.315 0.076 DBMET00968 | DBMET01365 | |
| 0.004 | 0.268 | 0.033 | Prostaglandin D2 antagonist | 0.033 0.01 DBMET01365 | DBMET01365 | |
| 0.093 | 0.362 | 0.124 | CC chemokine 6 receptor antagonist | 0.123 0.103 DBMET01111 0.124 0.094 DBMET00981 0.124 0.097 DBMET00968 | DBMET00968 | |
| 0.024 | 0.294 | 0.087 | 5-Lipoxygenase inhibitor | 0.087 0.074 DBMET01365 | DBMET01365 | |
| 0.004 | 0.286 | 0.047 | Prostaglandin agonist | 0.047 0.011 DBMET01365 | DBMET01365 | |
| 0.034 | 0.329 | 0.201 | Xanthine oxidase inhibitor | 0.201 0.019 DBMET01365 0.089 0.073 DBMET01111 | DBMET01365 | |
| 0.039 | 0.335 | 0.182 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.177 0.108 DBMET00936 0.182 0.105 DBMET00938 | DBMET00938 | |
| 0.014 | 0.311 | 0.052 | H+/K+-transporting ATPase inhibitor | 0.052 0.034 DBMET00937 | DBMET00937 | |
| 0.005 | 0.308 | 0.099 | Prostacyclin antagonist | 0.099 0.005 DBMET01365 | DBMET01365 | |
| 0.038 | 0.342 | 0.133 | Mcl-1 antagonist | 0.133 0.109 DBMET01365 | DBMET01365 | |
| 0.011 | 0.316 | 0.04 | Dihydroorotase inhibitor | 0.04 0.038 DBMET01365 | DBMET01365 | |
| 0.015 | 0.327 | 0.087 | Adrenaline uptake inhibitor | 0.087 0.023 DBMET00942 | DBMET00942 | |
| 0.042 | 0.359 | 0.225 | Dual specificity phosphatase inhibitor | 0.225 0.044 DBMET01365 0.174 0.071 DBMET01112 0.186 0.063 DBMET00969 0.2 0.055 DBMET00937 0.193 0.059 DBMET01113 | DBMET01365 | |
| 0.056 | 0.377 | 0.206 | Streptokinase A inhibitor | 0.206 0.129 DBMET00936 | DBMET00936 | |
| 0.036 | 0.357 | 0.17 | Dyrk kinase inhibitor | 0.161 0.125 DBMET00936 0.17 0.118 DBMET00938 | DBMET00938 | |
| 0.001 | 0.323 | 0.07 | Prostaglandin EP4 agonist | 0.07 0.004 DBMET01365 | DBMET01365 | |
| 0.009 | 0.365 | 0.177 | NMDA 2B receptor antagonist | 0.07 0.025 DBMET00938 0.108 0.014 DBMET01112 0.096 0.016 DBMET00969 0.151 0.009 DBMET00937 0.177 0.007 DBMET01113 | DBMET01113 | |
| 0.017 | 0.379 | 0.116 | M17 leucyl aminopeptidase inhibitor | 0.116 0.082 DBMET01365 | DBMET01365 | |
| 0.033 | 0.41 | 0.298 | Phospholipase A2 inhibitor | 0.298 0.014 DBMET01365 | DBMET01365 | |
| 0.036 | 0.421 | 0.213 | Arachidonic acid antagonist | 0.213 0.022 DBMET01365 | DBMET01365 | |
| 0.012 | 0.399 | 0.346 | Cholecystokinin B agonist | 0.321 0.003 DBMET01112 0.321 0.003 DBMET00969 0.346 0.003 DBMET00937 0.346 0.003 DBMET01113 | DBMET01113 | |
| 0.006 | 0.4 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.02 DBMET00981 0.022 0.019 DBMET00968 | DBMET00968 | |
| 0.024 | 0.442 | 0.127 | Multidrug resistance-associated protein 1 inhibitor | 0.12 0.048 DBMET01112 0.127 0.041 DBMET00969 0.113 0.058 DBMET00937 0.111 0.06 DBMET01113 | DBMET00969 | |
| 0.029 | 0.447 | 0.208 | Dual specificity phosphatase 3 inhibitor | 0.208 0.056 DBMET01365 0.157 0.091 DBMET01112 0.171 0.08 DBMET00969 0.188 0.068 DBMET00937 0.182 0.072 DBMET01113 | DBMET01365 | |
| 0.008 | 0.428 | 0.052 | Leukotriene B4 antagonist | 0.052 0.041 DBMET01365 | DBMET01365 | |
| 0.013 | 0.436 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 DBMET01111 0.051 0.013 DBMET00981 0.051 0.013 DBMET00968 | DBMET00968 | |
| 0.035 | 0.465 | 0.126 | Transcription factor NF kappa B stimulant | 0.126 0.023 DBMET01111 0.081 0.066 DBMET00981 0.086 0.057 DBMET00968 | DBMET01111 | |
| 0.004 | 0.439 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.022 DBMET01112 0.028 0.021 DBMET00969 0.029 0.018 DBMET00937 0.029 0.019 DBMET01113 | DBMET01113 | |
| 0.069 | 0.505 | 0.207 | Insulysin inhibitor | 0.207 0.146 DBMET01365 0.196 0.162 DBMET00942 | DBMET01365 | |
| 0.008 | 0.452 | 0.052 | Plasminogen activator inhibitor antagonist | 0.052 0.03 DBMET01365 | DBMET01365 | |
| 0.006 | 0.451 | 0.07 | Leukotriene antagonist | 0.07 0.04 DBMET01365 | DBMET01365 | |
| 0.005 | 0.455 | 0.064 | Prostaglandin antagonist | 0.064 0.029 DBMET01365 | DBMET01365 | |
| 0.057 | 0.525 | 0.249 | Histamine release inhibitor | 0.249 0.156 DBMET01365 | DBMET01365 | |
| 0.031 | 0.498 | 0.129 | Cyclooxygenase 3 inhibitor | 0.105 0.096 DBMET01365 0.129 0.068 DBMET01111 | DBMET01111 | |
| 0.029 | 0.499 | 0.311 | Free radical scavenger | 0.311 0.049 DBMET01111 0.293 0.054 DBMET00981 0.305 0.05 DBMET00968 | DBMET01111 | |
| 0.049 | 0.523 | 0.328 | Antithrombotic | 0.206 0.169 DBMET01365 0.283 0.1 DBMET01111 0.328 0.073 DBMET00981 0.303 0.086 DBMET00968 | DBMET00981 | |
| 0.005 | 0.481 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 DBMET00938 | DBMET00938 | |
| 0.051 | 0.533 | 0.223 | Cholesterol antagonist | 0.223 0.146 DBMET01365 | DBMET01365 | |
| 0.026 | 0.519 | 0.12 | Aldehyde dehydrogenase inhibitor | 0.12 0.071 DBMET01365 | DBMET01365 | |
| 0.054 | 0.556 | 0.247 | Immunomodulator | 0.227 0.135 DBMET01111 0.247 0.118 DBMET00981 | DBMET00981 | |
| 0.015 | 0.521 | 0.111 | Cystathionine beta-synthase inhibitor | 0.111 0.065 DBMET01365 | DBMET01365 | |
| 0.006 | 0.544 | 0.109 | Monophenol monooxygenase inhibitor | 0.109 0.069 DBMET01365 | DBMET01365 | |
| 0.008 | 0.553 | 0.05 | Aconitate hydratase inhibitor | 0.05 0.038 DBMET01365 | DBMET01365 | |
| 0.003 | 0.555 | 0.153 | Cholecystokinin A agonist | 0.138 0.003 DBMET01112 0.141 0.003 DBMET00969 0.153 0.003 DBMET00937 0.149 0.003 DBMET01113 | DBMET00937 | |
| 0.024 | 0.577 | 0.102 | DNA polymerase I inhibitor | 0.102 0.084 DBMET01365 | DBMET01365 | |
| 0.003 | 0.557 | 0.173 | Cholecystokinin agonist | 0.154 0.004 DBMET01112 0.159 0.003 DBMET00969 0.173 0.003 DBMET00937 0.167 0.003 DBMET01113 | DBMET00937 | |
| 0.022 | 0.579 | 0.155 | DNA methyltransferase I inhibitor | 0.155 0.099 DBMET01365 | DBMET01365 | |
| 0.011 | 0.572 | 0.098 | Mucolytic | 0.098 0.08 DBMET01365 | DBMET01365 | |
| 0.065 | 0.629 | 0.258 | 5 Hydroxytryptamine release inhibitor | 0.258 0.217 DBMET01365 | DBMET01365 | |
| 0.012 | 0.589 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 DBMET01111 | DBMET01111 | |
| 0.008 | 0.588 | 0.107 | Expectorant | 0.107 0.062 DBMET01365 | DBMET01365 | |
| 0.026 | 0.611 | 0.165 | Tumour necrosis factor alpha release inhibitor | 0.165 0.14 DBMET00981 0.157 0.149 DBMET00968 | DBMET00981 | |
| 0.01 | 0.595 | 0.059 | Heparanase inhibitor | 0.059 0.024 DBMET01111 | DBMET01111 | |
| 0.018 | 0.609 | 0.129 | Triose-phosphate isomerase inhibitor | 0.129 0.028 DBMET01365 | DBMET01365 | |
| 0.017 | 0.611 | 0.413 | Angiogenesis stimulant | 0.413 0.02 DBMET01111 0.38 0.025 DBMET00981 0.201 0.094 DBMET01112 0.389 0.024 DBMET00968 0.221 0.084 DBMET00969 0.26 0.065 DBMET00937 0.243 0.073 DBMET01113 | DBMET01111 | |
| 0.015 | 0.616 | 0.179 | Thrombolytic | 0.153 0.08 DBMET01111 0.179 0.062 DBMET00981 0.129 0.1 DBMET00968 | DBMET00981 | |
| 0.02 | 0.626 | 0.158 | DNA methylase inhibitor | 0.158 0.111 DBMET01365 | DBMET01365 | |
| 0.008 | 0.617 | 0.06 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET01111 0.059 0.032 DBMET00981 0.06 0.031 DBMET00968 | DBMET00968 | |
| 0.017 | 0.636 | 0.101 | Electrolyte absorption antagonist | 0.101 0.057 DBMET01365 | DBMET01365 | |
| 0.011 | 0.631 | 0.088 | GABA C receptor agonist | 0.088 0.082 DBMET01365 | DBMET01365 | |
| 0.02 | 0.64 | 0.183 | Nitric oxide antagonist | 0.176 0.078 DBMET01111 0.183 0.074 DBMET00981 0.181 0.076 DBMET00968 | DBMET00981 | |
| 0.005 | 0.632 | 0.224 | Selectin antagonist | 0.195 0.012 DBMET01111 0.224 0.009 DBMET00981 0.071 0.042 DBMET01112 0.186 0.013 DBMET00968 0.077 0.038 DBMET01113 | DBMET00981 | |
| 0.057 | 0.688 | 0.179 | Tyrosine 3 hydroxylase inhibitor | 0.179 0.177 DBMET01365 | DBMET01365 | |
| 0.018 | 0.652 | 0.18 | DNA synthesis inhibitor | 0.18 0.153 DBMET01111 | DBMET01111 | |
| 0.014 | 0.657 | 0.278 | Platelet antagonist | 0.278 0.061 DBMET01365 | DBMET01365 | |
| 0.005 | 0.66 | 0.056 | Leukotriene C antagonist | 0.056 0.039 DBMET01365 | DBMET01365 | |
| 0.039 | 0.694 | 0.34 | Apoptosis agonist | 0.293 0.177 DBMET01111 0.34 0.145 DBMET00981 0.264 0.2 DBMET00968 | DBMET00981 | |
| 0.011 | 0.672 | 0.214 | Anticoagulant | 0.179 0.062 DBMET01112 0.135 0.095 DBMET00969 0.169 0.067 DBMET00937 0.214 0.048 DBMET01113 | DBMET01113 | |
| 0.02 | 0.683 | 0.093 | Toll-Like receptor 4 antagonist | 0.093 0.082 DBMET01111 0.093 0.082 DBMET00968 | DBMET00968 | |
| 0.016 | 0.694 | 0.197 | Transcription factor NF kappa B inhibitor | 0.197 0.172 DBMET01111 | DBMET01111 | |
| 0.021 | 0.712 | 0.477 | Antibacterial | 0.32 0.121 DBMET01111 0.477 0.047 DBMET00981 0.418 0.069 DBMET00968 | DBMET00981 | |
| 0.011 | 0.712 | 0.138 | Alpha-N-acetylglucosaminidase inhibitor | 0.138 0.063 DBMET01365 | DBMET01365 | |
| 0.003 | 0.712 | 0.032 | Cholecystokinin B antagonist | 0.027 0.025 DBMET01112 0.028 0.023 DBMET00969 0.032 0.02 DBMET00937 0.032 0.02 DBMET01113 | DBMET01113 | |
| 0.003 | 0.744 | 0.046 | Cholecystokinin antagonist | 0.037 0.031 DBMET00969 0.045 0.027 DBMET00937 0.046 0.027 DBMET01113 | DBMET01113 | |
| 0.009 | 0.753 | 0.165 | Immunostimulant | 0.165 0.142 DBMET01111 | DBMET01111 | |
| 0.011 | 0.76 | 0.172 | Succinate dehydrogenase inhibitor | 0.172 0.078 DBMET01365 | DBMET01365 | |
| 0.003 | 0.755 | 0.065 | Cholecystokinin A antagonist | 0.048 0.02 DBMET01112 0.051 0.019 DBMET00969 0.063 0.016 DBMET00937 0.065 0.015 DBMET01113 | DBMET01113 | |
| 0.026 | 0.785 | 0.446 | Antiinflammatory | 0.446 0.112 DBMET00981 0.403 0.137 DBMET00968 | DBMET00981 | |
| 0.017 | 0.787 | 0.228 | Immunosuppressant | 0.228 0.168 DBMET00981 | DBMET00981 | |
| 0.047 | 0.849 | 0.269 | Interleukin 2 agonist | 0.267 0.101 DBMET01111 0.269 0.099 DBMET00981 0.269 0.099 DBMET00968 | DBMET00968 | |
| 0.002 | 0.837 | 0.036 | Prostaglandin D2 agonist | 0.036 0.015 DBMET01365 | DBMET01365 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |